← Company directoryNASDAQ · SEC EDGAR
Revelation Biosciences, Inc.
REVBA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Revelation Biosciences 1-for-7 reverse split effective
Revelation Biosciences' 1-for-7 common-stock reverse split becomes effective the morning of October 20. Fractional shares will be rounded up to the next whole share; common-stock par value remains unchanged.
Revelation Biosciences ↗Revelation Biosciences split-adjusted trading begins
Revelation Biosciences common stock begins 1-for-7 split-adjusted trading at Nasdaq's October 20 open under the unchanged REVB symbol. The new CUSIP will be 76135L887.
Revelation Biosciences ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
RENTRent the Runway, Inc.NASDAQ · SEC→RENXRenX Enterprises Corp.NASDAQ · SEC→REPLReplimune Group, Inc.NASDAQ · SEC→RETOReTo Eco-Solutions, Inc. - Class A SharesNASDAQ · SEC→REVBWRevelation Biosciences, Inc. - WarrantNASDAQ · SEC→REYNReynolds Consumer Products Inc.NASDAQ · SEC→RFAIRF Acquisition Corp IINASDAQ · SEC→RFAIRRF Acquisition Corp II - RightNASDAQ · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.